First Horizon Corporation (FHN) — Fair Value Analysis
Base-case fair value (P50): $23.92 · Current price: $25.64 · Verdict: Fairly Valued
The Verdict on FHN
Based on our proprietary Monte Carlo simulations, FIRST HORIZON CORP (FHN) is currently Overvalued. The rigorous simulation, which models thousands of forward scenarios by projecting key financial metrics and applying various valuation methodologies, pegs FHN's P50 median fair value at $23.92. This calculated value stands in stark contrast to its current trading price of $25.64, indicating a significant -6.7% discrepancy against our fair value estimate. This suggests that the market may be pricing in a more optimistic outlook for FHN than our comprehensive fundamental modeling supports, firmly placing the stock in overvalued territory and warranting investor scrutiny.
How FHN stacks up against peers
While FHN's sector is not provided, its quality tier is currently "unrated," meaning our operational and financial health assessment versus sector peers has not yet been assigned. This lack of an assigned quality tier implies that investors do not have a comparative benchmark from our analysis regarding FHN's relative strength or weakness within its industry group. Despite this, the $23.92 fair value derived from our Monte Carlo simulations remains the core anchor for our assessment. This highlights the substantial premium at which FHN is currently trading relative to its fundamental value, underscored by the disparity with its $25.64, even without a formal quality rating.
What this means for investors
For investors considering FHN, the Overvalued verdict, coupled with the -6.7% gap between its current $25.64 and the $23.92 median fair value, signals a potential downside risk. While our simulations account for a broad range of market conditions, the current valuation suggests that a significant premium is built into the stock, demanding careful consideration. Without an assigned quality tier to benchmark FHN's operational health against its peers, the emphasis for immediate action falls squarely on the Monte Carlo derived fair value. To gain a complete perspective, including the full bear-case and bull-case distribution and track FHN's fair value as new fundamentals are released, sign up for a free FairCurve account.
Frequently Asked Questions
Is FHN overvalued or undervalued right now?
FHN is considered overvalued, with its current trading price of $25.64 exceeding our median fair value estimate of $23.92.
What is the bear case and bull case for FHN?
The full Monte Carlo distribution, including bear (P10) and bull (P90) targets, along with the probability of upside, is available with a free FairCurve account. We do not provide specific dollar values here.
How does FairCurve calculate FHN's fair value?
FairCurve calculates FHN's fair value using a sophisticated Monte Carlo simulation that models thousands of forward scenarios based on various financial inputs.
How can I track FHN's fair value as it changes?
You can add FHN to a free FairCurve watchlist to receive daily fair-value updates and instant re-valuation whenever new earnings are released.